Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunopathogenesis of atherosclerosis.

Burkhard Ludewig1, Philippe Krebs, Elke Scandella

  • 1Research Departmrnt, Kantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland. Burkhard.Ludewig@kssg.ch

Journal of Leukocyte Biology
|March 25, 2004
PubMed
Summary

Microbial infections significantly impact atherosclerosis development. Targeting these pathogens and the resulting immune responses offers new treatment strategies for this vascular disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic alterations in the irradiated draining lymph node.

NPJ precision oncology·2026
Same author

Myocardial Immune Niches in Homeostasis and Inflammation.

Immunological reviews·2026
Same author

PMGen: from peptide-MHC structure prediction to peptide generation.

Bioinformatics (Oxford, England)·2026
Same author

Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage.

British journal of cancer·2026
Same author

The roles and diversity of alarmins in the mucosae.

Advances in immunology·2026
Same author

IL-33-induced ILC2 effector cytokine responses promote the expansion of red pulp macrophages.

Proceedings of the National Academy of Sciences of the United States of America·2026

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Infectious Diseases

Background:

  • Atherosclerosis development is increasingly linked to microbial infections.
  • Pathogen burden critically influences disease progression.
  • Vascular wall cells can be targeted by microbes, initiating injury.

Purpose of the Study:

  • To explore the role of microbial infections in atherogenesis.
  • To understand the immunopathological mechanisms driving chronic vascular inflammation.
  • To identify new therapeutic targets for atherosclerosis.

Main Methods:

  • Review of recent clinical studies on pathogen burden in atherosclerosis.
  • Analysis of microbial tropism for vascular wall cells.
  • Examination of immunopathological processes (molecular mimicry, epitope spreading, bystander activation).

Main Results:

  • Microbial infections, or pathogen burden, are critical determinants of atherosclerotic disease.
  • Viruses/bacteria can cause vascular injury directly or via autoimmune responses.
  • Immunopathological mechanisms fuel chronic inflammation in the vascular wall.

Conclusions:

  • Atherogenesis is a pathogen-driven, immunopathological process.
  • This understanding opens avenues for novel treatments.
  • Vaccination and immunomodulation are potential therapeutic strategies for atherosclerosis.

Related Experiment Videos